Key Takeaways:Moxie raised a $25 million Series C to bring clinical-grade operating infrastructure to independent aesthetic practices.The company simultaneously launched Scale Suite, a new product offering that brings multi-provider operational infrastructure, margin intelligence, and AI-driven compliance alerts.Moxie-supported practices grow 60% faster than the industry average and achieve 10% higher margin.The Series C brings Moxie, the clinical-grade operating system for aesthetic medicine, to a total of $51 million in funding.WHO: Founded in 2022, Moxie is a provider of management solutions to empower independent medspas with the tools and expertise usually available only to the largest chains and private equity rollups. Moxie offers independent medspas a business-in-a-box suite of solutions that provide entrepreneurs with secure medical charting, scheduling and billing software, compliance tracking, and marketing tools and services while matching them with a medical director, insurance, an ongoing business coach, and up to 55% discounts on critical supplies.Moxie was founded on a pattern its team observed across hundreds of aesthetic practices: the most successful ones operated with clinical and operational rigor—structured workflows, financial clarity, compliance discipline, and leadership systems that didn’t depend on the owner being in the room for everything to work.WHY: Aesthetic medicine is one of the fastest-growing specialties in healthcare. As the specialty has grown, so has the pressure on practice owners. The new investment will accelerate the company’s mission to make clinically led growth the standard in aesthetic medicine.